Takara Bio Inc.
Notice Regarding the Result of the Tender Offer for Our Common Shares by Our Parent Company Takara Holdings Inc.
Takara Holdings Inc. conducted a tender offer for 47,065,467 common shares of Takara Bio Inc. from February 16 to April 6, 2026, and purchased all 31,733,101 shares tendered.
Key Figures
- Scheduled Purchase Quantity: 47,065,467 shares
- Number of Tendered Shares: 31,733,101 shares
- Purchase Price: 1,150 JPY/share
- Voting Rights Ownership Ratio After Purchase: 87.27%
- Tender Offer Period: 2026-02-16 to 2026-04-06
AI要約
Overview of the Tender Offer
Takara Holdings Inc. conducted a tender offer for 47,065,467 common shares of Takara Bio Inc. from February 16 to April 6, 2026. The purchase price was 1,150 JPY per share. The number of shares tendered reached 31,733,101, and Takara Holdings purchased all tendered shares. After the purchase, Takara Holdings' voting rights ownership ratio became 87.27%.
Future Outlook and Delisting Schedule
Following the results of the tender offer, Takara Bio Inc.'s common shares are scheduled to be delisted from the Tokyo Stock Exchange Prime Market after completing the required procedures. Once delisted, trading of the shares will no longer be possible. Subsequently, the company is expected to transition to a structure in which only the tender offeror is a shareholder via squeeze-out procedures. Details will be promptly disclosed once finalized.
